| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/19/2004 | WO2004014960A2 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/12/2004 | US20040030126 Process for synthesizing beta-lactam |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/04/2004 | EP1385548A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/03/2004 | US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019033 Mandelic acid derivatives and their use as throbin inhibitors |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1000016B1 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives. |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/27/2004 | US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
| 01/27/2004 | US6683176 Intermediates for and synthesis of 3-methylene cephams |
| 01/22/2004 | WO2004007446A1 Novel azetidine derivative or salt thereof |
| 01/22/2004 | WO2004007444A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/21/2004 | EP1381668A1 Compounds, compositions, and methods for controlling biofilms |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
| 01/15/2004 | WO2004005247A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 01/15/2004 | CA2492035A1 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/15/2004 | CA2491789A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | DE10227508A1 Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Acid group-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10227507A1 Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Cationically substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/02/2004 | EP1375495A1 Method for producing 2-azetidinone derivative |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 12/31/2003 | WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | WO2004000803A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 12/31/2003 | CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
| 12/31/2003 | CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
| 12/24/2003 | WO2003106390A1 Polymerisation inhibitor |
| 12/24/2003 | WO2002028829A3 Peptide deformylase inhibitors |
| 12/18/2003 | WO2003053431A3 Pharmaceutical compositions based on azetidine derivatives |
| 12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | WO2003101957A1 New salts |
| 12/11/2003 | WO2003101956A1 Pharmaceutical combination |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003101423A1 Immediate release pharmaceutical formulation |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
| 12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | CA2487509A1 New salts |
| 12/11/2003 | CA2486110A1 Pharmaceutical combination |
| 12/11/2003 | CA2485533A1 Immediate release pharmaceutical formulation |
| 12/10/2003 | EP1368328A1 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 12/10/2003 | CN1130342C Process for synthesis of beta-propanamide |
| 12/04/2003 | US20030225271 Compounds useful as reversible inhibitors of cysteine proteases |
| 12/04/2003 | US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 12/03/2003 | EP1170287B1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids |
| 12/03/2003 | CN1129604C Amino acid derivatives and their use as thrombin inhibitors |
| 11/27/2003 | WO2003037338A3 Modulators of the cholesterol biosynthetic pathway |
| 11/27/2003 | WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor |
| 11/27/2003 | US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates |
| 11/27/2003 | US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia |
| 11/27/2003 | US20030220324 Substituted piperazines and methods of use |
| 11/26/2003 | EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same |
| 11/26/2003 | CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors |
| 11/25/2003 | US6653490 Process for the preparation of ammonium alkoxides |
| 11/25/2003 | CA2106370C Antibiotic compounds |
| 11/24/2003 | CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof |
| 11/20/2003 | WO2003050154A3 Catalytic carbonylation of three and four membered heterocycles |
| 11/20/2003 | WO2002058731A3 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 11/20/2003 | US20030216434 Cyclic derivatives as modulators of chemokine receptor activity |
| 11/20/2003 | US20030216383 Compounds useful as reversible inhibitors of cysteine proteases |
| 11/18/2003 | US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 11/13/2003 | US20030212067 Bone disorders; rheumatic diseases; wound healing agents |
| 11/12/2003 | EP1361222A1 Sidechain-bearing taxanes |
| 11/12/2003 | CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists |
| 11/12/2003 | CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 11/12/2003 | CN1455679A Use of melagatran for manufacture of medicament for treatment of ischemic disorders |
| 11/11/2003 | US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals |
| 11/11/2003 | US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors |
| 11/06/2003 | WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors |
| 11/04/2003 | CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives |
| 11/04/2003 | CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components |
| 10/30/2003 | US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
| 10/29/2003 | EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/29/2003 | EP1355644A2 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 10/29/2003 | EP1089964B1 Hydrazine derivatives |
| 10/28/2003 | US6638980 Inhibitors of factor Xa |
| 10/23/2003 | WO2003086388A1 Estrogen receptor modulators |
| 10/23/2003 | US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia |
| 10/22/2003 | EP1353695A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |